MAP Sciences Group Announcement

Under the wise joint leadership of the executive team; its CEO, CSO and COO; MAP Sciences has overcome many challenges over the last few years, driven by their strong belief in MAP’s technology, their passionate commitment to the success of the business, their continuous financial support to the group companies, and of course the dedicated support of MAP’s incredible staff.

MAP Sciences is now in a good position to move confidently to the next phase of its growth strategy and compete globally.

It is with great honor that we announce the new leadership roles in the MAP Sciences Group.

Tarek Sultani Makhzoumi will assume the role of MAP Sciences Group CEO alongside his other executive responsibilities in the group companies in the UK, the USA and the GCC, and will continue to lead the implementation of MAP’s strategy, develop partnerships and oversee the management of all operations in the different geographies.

Professor Ray Kruse Iles will increase his responsibilities and assume the global role of MAP Sciences Group Chief Scientific Officer and focus on the USA and Europe alongside his other executive responsibilities in the group companies in the UK and the GCC and will continue his diligent frontier development approach of new screening tests with the support of his team of talented scientists.

Raminta Zmuidinaite will assume the role of MAP Sciences Group Senior Research Scientist and directly support the expansion into the USA alongside her other research responsibilities in the group companies in the UK, as the most senior member of Professor Iles’ team of talented scientists.

Ziad Sultani Makhzoumi will assume the role of MAP Sciences Group Chairman alongside his other executive responsibilities in the GCC and the USA and will focus on developing MAP’s growth strategy and support its implementation globally.